Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVM

Alternate Symbol(s):  PAVMZ

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed Announces Temporary Offer Allowing Warrants to Be Exercised at a Reduced Price

Business Wire December 28, 2017

Fierce Innovation Awards 2017 Recognizes PAVmed’s CarpX™ Device for Technology Innovation

Business Wire December 18, 2017

PAVmed Files 510(k) Submission with FDA for CarpX™ Device to Treat Carpal Tunnel Syndrome

Business Wire November 28, 2017

PAVmed to Host Earnings Call

Accesswire November 16, 2017

PAVmed Reports Third Quarter 2017 Financial Results

Business Wire November 15, 2017

PAVmed Inc. to Hold Business Update Conference Call on November 16th

Business Wire November 9, 2017

PAVmed to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference

Business Wire October 10, 2017

12 Biggest Mid-Day Losers For Thursday

Benzinga.com  September 21, 2017

PAVmed to Present at the Cantor Fitzgerald Global Healthcare Conference

Business Wire September 18, 2017

PAVmed Reports Second Quarter 2017 Financial Results

Business Wire August 14, 2017

PAVmed Inc. to Hold Business Update Conference Call on August 17th

Business Wire August 9, 2017

PAVmed Inc. Closes $5 Million Financing

Business Wire July 5, 2017

PAVmed Announces Effectiveness of Form S-1 Resale Registration Statement

Business Wire June 23, 2017

PAVmed to Join Russell Microcap® Index

Business Wire June 22, 2017

PAVmed Reports First Quarter 2017 Financial Results and Provides Business Update

Business Wire May 22, 2017

PAVmed Inc. Postpones Business Update Conference Call to May 31st

Business Wire May 16, 2017

PAVmed Inc. to Hold Business Update Conference Call on May 17th

Business Wire May 10, 2017

PAVmed Announces Filing of Exchange Offer Registration Statement with the SEC

Business Wire April 10, 2017

PAVmed Announces Revised Presentation Time at the 16th Annual Needham Healthcare Conference

Business Wire March 31, 2017

PAVmed to Present at the 16th Annual Needham Healthcare Conference

Business Wire March 28, 2017